Nadine A M E van der Beek (N A M E van der Beek, Nadine Ame van der Beek)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Replacement Therapy

Top Venues

European journal of neurology

European journal of human genetics : EJHG

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Aglina Lika, Eleni-Rosalina Andrinopoulou, Nadine A M E van der Beek, Dimitris Rizopoulos, Ans T van der Ploeg, Michelle E Kruijshaar
Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease. European journal of neurology 31 (5) (2024)
Chloé F Najac, Nadine A M E van der Beek, Vincent Oltman Boer, Pieter A van Doorn, Ans T van der Ploeg, Itamar Ronen, Hermien E Kan, Johanna M P van den Hout
Brain glycogen build-up measured by magnetic resonance spectroscopy in classic infantile Pompe disease. Brain communications 6 (5) (2024)
Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield, Esther Brusse, Jordi Díaz-Manera, Andreas Hahn, Thomas Hundsberger, Cornelia Kornblum, Michelle Kruijshaar, Pascal Laforêt, Eugen Mengel, Tiziana Mongini, David Orlikowski, Giancarlo Parenti, W W M Pim Pijnappel, Mark Roberts, Thomas Scherer, Antonio Toscano, John Vissing, Johanna M P van den Hout, Pieter A van Doorn, Stephan Wenninger, Ans T van der Ploeg
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. European journal of neurology (2024)
Harmke A van Kooten, Mike C Horton, Stephan Wenninger, Haris Babačić, Benedikt Schoser, Claire Lefeuvre, Najib Taouagh, Pascal Laforêt, Sonia Segovia, Jordi Díaz-Manera, Kristl G Claeys, Tiziana Mongini, Olimpia Musumeci, Antonio Toscano, Thomas Hundsberger, Esther Brusse, Pieter A van Doorn, Ans T van der Ploeg, Nadine A M E van der Beek, null null
Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale. European journal of neurology (2024)
Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield, Esther Brusse, Jordi Díaz-Manera, Andreas Hahn, Thomas Hundsberger, Cornelia Kornblum, Michelle Kruijshaar, Pascal Laforêt, Eugen Mengel, Tiziana Mongini, David Orlikowski, Giancarlo Parenti, W W M Pim Pijnappel, Mark Roberts, Thomas Scherer, Antonio Toscano, John Vissing, Johanna M P van den Hout, Pieter A van Doorn, Stephan Wenninger, Ans T van der Ploeg
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. European journal of neurology 31 (9) (2024)
Aglina Lika, Eleni-Rosalina Andrinopoulou, Nadine A M E van der Beek, Dimitris Rizopoulos, Ans T van der Ploeg, Michelle E Kruijshaar
Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease. European journal of neurology 31 (5) (2024)
Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield, Esther Brusse, Jordi Díaz-Manera, Andreas Hahn, Thomas Hundsberger, Cornelia Kornblum, Michelle Kruijshaar, Pascal Laforêt, Eugen Mengel, Tiziana Mongini, David Orlikowski, Giancarlo Parenti, W W M Pim Pijnappel, Mark Roberts, Thomas Scherer, Antonio Toscano, John Vissing, Johanna M P van den Hout, Pieter A van Doorn, Stephan Wenninger, Ans T van der Ploeg
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. European journal of neurology 31 (9) (2024)
Aglina Lika, Eleni-Rosalina Andrinopoulou, Nadine A M E van der Beek, Dimitris Rizopoulos, Ans T van der Ploeg, Michelle E Kruijshaar
Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease. European journal of neurology (2024)
Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield, Esther Brusse, Jordi Díaz-Manera, Andreas Hahn, Thomas Hundsberger, Cornelia Kornblum, Michelle Kruijshaar, Pascal Laforêt, Eugen Mengel, Tiziana Mongini, David Orlikowski, Giancarlo Parenti, W W M Pim Pijnappel, Mark Roberts, Thomas Scherer, Antonio Toscano, John Vissing, Johanna M P van den Hout, Pieter A van Doorn, Stephan Wenninger, Ans T van der Ploeg
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. European journal of neurology 31 (9) (2024)
Aglina Lika, Eleni-Rosalina Andrinopoulou, Nadine A M E van der Beek, Dimitris Rizopoulos, Ans T van der Ploeg, Michelle E Kruijshaar
Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease. European journal of neurology 31 (5) (2024)
Imke A M Ditters, Harmke A van Kooten, Nadine A M E van der Beek, Jacqueline F Hardon, Gamida Ismailova, Esther Brusse, Michelle E Kruijshaar, Ans T van der Ploeg, Johanna M P van den Hout, Hidde H Huidekoper
Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
M J Mackenbach, Eline A J Willemse, Jan J A van den Dorpel, Nadine A M E van der Beek, Jordi Díaz-Manera, D Rizopoulos, Charlotte E Teunissen, Ans T van der Ploeg, Johanna M P van den Hout
Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease. Neurology (2023)
Maudy T M Theunissen, Renee M van den Elsen, Tiffany L House, Brad Crittenden, Pieter A van Doorn, Ans T van der Ploeg, Michelle E Kruijshaar, Nadine A M E van der Beek
The impact of COVID-19 infection, the pandemic and its associated control measures on patients with Pompe disease. Journal of neurology (2023)
Mazen M Dimachkie, Priya S Kishnani, Cristina Ivanescu, Giulio Flore, Chad Gwaltney, Nadine A M E van der Beek, Alaa Hamed, Kristina An Haack, Laurence Pollissard, Eileen Baranowski, Susan E Sparks, Pronabesh DasMahapatra, null null
Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study. Neurology. Clinical practice 13 (5) (2023)
Harmke A van Kooten, Imke A M Ditters, Marianne Hoogeveen-Westerveld, Edwin H Jacobs, Johanna M P van den Hout, Pieter A van Doorn, W W M Pim Pijnappel, Ans T van der Ploeg, Nadine A M E van der Beek
Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease. Orphanet journal of rare diseases 17 (1) (2022)
Monica Y Niño, Mark Wijgerde, Douglas Oliveira Soares de Faria, Marianne Hoogeveen-Westerveld, Atze J Bergsma, Mike Broeders, Nadine A M E van der Beek, Hannerieke J M van den Hout, Ans T van der Ploeg, Frans W Verheijen, W W M Pim Pijnappel
Enzymatic diagnosis of Pompe disease: lessons from 28 years of experience. European journal of human genetics : EJHG 29 (3) (2020)
Nadine A M E van der Beek, Isabelle Nelson, Roseline Froissart, Thierry Levade, Virginie Garcia, Emmanuelle Lacene, Anne Boland, Cécile Masson, Norma B Romero, Tanya Stojkovic, Gisèle Bonne, Anthony Béhin
A new case of SMA phenotype without epilepsy due to biallelic variants in ASAH1. European journal of human genetics : EJHG 27 (3) (2018)
Esther Kuperus, Jan C van der Meijden, Stijn L M In 't Groen, Marian A Kroos, Marianne Hoogeveen-Westerveld, Dimitris Rizopoulos, Monica Yasmin Nino Martinez, Michelle E Kruijshaar, Pieter A van Doorn, Nadine A M E van der Beek, Ans T van der Ploeg, W W M Pim Pijnappel
The ACE I/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease. PloS one 13 (12) (2018)